Case details

Court: ded
Docket #: 1:16-cv-00398
Case Name: AbbVie Inc. v. Amneal Pharmaceuticals, LLC et al
PACER case #: 59492
Date filed: 2016-05-27
Date terminated: 2016-09-06
Assigned to: Judge Richard G. Andrews
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
AbbVie Inc.
Plaintiff
 
Mary B. Graham
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: mbgefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Derek James Fahnestock
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
302-658-9200
Email: dfahnestock@mnat.com
ATTORNEY TO BE NOTICED

Stephen J. Kraftschik
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
302-351-9378
Email: skraftschik@mnat.com
ATTORNEY TO BE NOTICED
Amneal Pharmaceuticals, LLC
Defendant
 
Anne Shea Gaza
Young, Conaway, Stargatt & Taylor LLP
Rodney Square
1000 North King Street
Wilmington, DE 19801
(302) 571-6727
Email: agaza@ycst.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Robert M. Vrana
Young, Conaway, Stargatt & Taylor LLP
Rodney Square
1000 North King Street
Wilmington, DE 19801
(302) 571-6600
Email: rvrana@ycst.com
ATTORNEY TO BE NOTICED
Amneal Pharmaceuticals of New York, LLC
Defendant
 
Anne Shea Gaza
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Robert M. Vrana
(See above for address)
ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2016-05-27 1 0 COMPLAINT filed against Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1938613.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sar) (Entered: 05/31/2016)
2016-05-27 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 05/31/2016)
2016-05-27 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 15, 2016. Date of Expiration of Patent: Patent No. 7,148,359: July 19, 2019 with an extension for pediatric exclusivity until: January 19, 2020 Patent No. 7,364,752: November 10, 2020 with an extension for pediatric exclusivity until: May 10, 2021.Thirty Month Stay Deadline: 10/15/2018. (sar) (Entered: 05/31/2016)
2016-05-27 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 C1;. (sar) (Entered: 05/31/2016)
2016-05-27 5 0 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (sar) (Entered: 05/31/2016)
2016-08-23 6 0 SUMMONS Returned Executed by AbbVie Inc.. Amneal Pharmaceuticals, LLC served on 8/23/2016, answer due 9/13/2016. (Kraftschik, Stephen) (Entered: 08/23/2016)
2016-08-23 7 0 SUMMONS Returned Executed by AbbVie Inc.. Amneal Pharmaceuticals of New York, LLC served on 8/23/2016, answer due 9/13/2016. (Kraftschik, Stephen) (Entered: 08/23/2016)
2016-09-02 8 0 STIPULATION of Dismissal by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, LLC. (Gaza, Anne) (Main Document 8 replaced on 9/6/2016) (nms). (Entered: 09/02/2016)
2016-09-06 9 0 SO ORDERED Granting 8 Joint Stipulation of Dismissal, filed by Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, LLC (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/6/2016. (nms) (Entered: 09/06/2016)
2016-09-07 10 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 C1. (Attachments: # 1 Order)(nms) (Entered: 09/07/2016)